Knosys does somersaults in last week’s ASX small cap winners and losers list
The most notable trend in our weekly small cap winners and losers tables was the sell-off in crypto and blockchain stocks.
Six related stocks made the worst 30 list (see below).
But first the good news.
Congrats to holders of Knosys (ASX:KNO) which had an absolute blinder, more than tripling from 5.5c to 18c over the past week.
The shares took off on Monday after the knowledge management platform announcing its biggest ever single contract with Singapore telco SingTel.
The $6 million deal will see Knosys’s KnowledgeIQ platform deployed across SingTel’s Singaporean business and Australian subsidiary Optus.
The contract is set to span five years for Singtel and three years for Optus, beginning immediately.
Knosys closed the week up 227 per cent — by far the best performing ASX small cap of the week.
It took two years, but former Papua New Guinea-focused explorer Foyson Resources re-listed on the ASX with a bang — as plastics-to-fuel tech play Integrated Green Energy.
Foyson announced the acquisition of Integrated Green Energy (ASX:IGE) a year ago. But after a series of false starts and four prospectuses the company successfully raised $6.5 million at 20c a share and completed the IGE deal.
Singapore-based IGE is marketing three technologies which turn plastic to fuel, biomass to energy and biomass to liquid fuel.
The stock soared 68 per cent last week after re-listing on Tuesday. The shares finished the week at 21c, up from its last traded price of 12.5c.
Here’s one to watch. Tiny Queste Communications (ASX:QUE) — worth just $2 million — jumped 54 per cent this week on no news — and then went into a trading halt on Friday.
The olive farmer told investors it planned to make an announcement on Tuesday.
The shares last traded at 7.4c, up from 4.8c the previous week.
Explorer Raven Energy (ASX:REL) — which doubled from 0.1c to 0.2c — also went into suspension “pending the release of an announcement regarding the finalisation of contemplated financing and associated corporate initiatives”.
“Internet of Lights” play Vivid Technology (ASX:VIV) lit up after telling investors its last quarter was its strongest growth to date.
The shares traded up as much as 75 per cent after the announcement and finished up 40 per cent for the week at 6.6c.
Vivid reported an increase in customer receipts for its ‘Lighting-as-a-Service’ product, up 182 per cent compared to the previous corresponding period, at $4.8 million.
Meanwhile after what has been a 20-year search for a treatment, Aussie junior pharma Immuron (ASX:IMC) believes its over-the-counter tablets could be the answer to Bali Belly.
Immuron this week released a study of its Travelan tablets by the US Department of Defense, which shows its effectiveness in preventing traveller’s diarrhoea.
Immuron shares soared on the news, closing the week up 30 per cent at 28.5c.
Chief Dr Jerry Kanellos told Stockhead the latest study was a strong verification of the product — which has been listed on the Australian Therapeutic Goods Administration since 2004.
“The US army data dwarfs the studies that we have done in the past,” Dr Kanellos said.
Here are the best performing ASX small cap stocks for Jan 25-Feb 2. (These tables may be best viewed on a laptop or desktop):
Crypto and blockchain was the worst performing sector among ASX small caps last week.
Reffind, First Growth Funds, Ookami, DigitalX, Fatfish and Zyber were all in the list of worst 30 performers, losing between 19 per cent and 34 per cent of their value. (See table below).
Even blockchain blockbuster Yojee was down 18 per cent from 28c to 23c.
The outlook in the coming week is pretty grim, too, with bitcoin and other currencies again falling on Friday night.
Elsewhere, mobile marketer Impelus (ASX:IMS) dropped 22 per cent to 3.9c after telling investors a key supplier — described as “a major telecommunications carrier” — was ceasing its service on March 2.
“Impelus’s strong position is that the carrier has a continuing obligation to provide it with the services,” the company told investors.
“…Premature withdrawal of the services in March 2018 would have a material impact on Impelus’s FY2018 revenue and earnings before interest and tax (EBITDA).”
Here are the worst performing ASX small cap stocks for Jan 25-Feb 2: